Lymphadenopathy clinical trials

The registry lists 77 studies for Lymphadenopathy across more than 10 countries. 14 are recruiting or about to start. 42 of them are mainly about Lymphadenopathy (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its narrower condition Immunoblastic Lymphadenopathy too: 349 studies, 27 open.

Get an email when these change. Save the Lymphadenopathy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 36
Status unknown: 17
Recruiting: 8
Not yet recruiting: 6
Active, not recruiting: 5
Withdrawn: 3

Phase

Phase 2: 11
Phase 1: 7
Phase 3: 2
Phase 4: 1

Where

United States: 29
China: 12
Germany: 6
Taiwan: 5
France: 4
Italy: 4

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (4) · M.D. Anderson Cancer Center (4) · China-Japan Friendship Hospital (4) · University College Hospital Galway (2) · Royal Brompton & Harefield NHS Foundation Trust (2) · Shanghai Chest Hospital (2) · Heidelberg University (2) · Massachusetts General Hospital (2)

What is being tested here

Drugs under test in Lymphadenopathy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Rituximab	0	0	2
Etoposide	0	0	1
Interferon Alpha	0	0	1
Zidovudine	0	0	1
Liposomal doxorubicin	0	0	1
Doxorubicin	0	0	1
Bortezomib	0	0	1
Valganciclovir	0	0	1
Ganciclovir	0	0	1
Vincristine	0	0	1

Coming up

0phase 3 studies under way

5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Dec 2026Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma · University of Southern California
Dec 2026A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery · Second Affiliated Hospital of Wenzhou Medical University
Apr 2027Safety and Performance Profile of Cryobiopsy in Bronchial Endoscopy · University Hospital, Strasbourg, France
Jul 2027Diagnostic Yield and Safety of Confocal Laser Endomicroscopy-Assisted Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration · China-Japan Friendship Hospital
Oct 2027Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes · Peking University Third Hospital

Who these studies take

Of the 8 Lymphadenopathy studies recruiting now, 8 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 8
Age	Women	Men
10	1 (13%)	1 (13%)
18	8 (100%)	8 (100%)
30	8 (100%)	8 (100%)
40	8 (100%)	8 (100%)
50	8 (100%)	8 (100%)
65	8 (100%)	8 (100%)
75	8 (100%)	8 (100%)
85	8 (100%)	8 (100%)

Across all 77 studies, recruiting or not: 5% stop at 75 or younger and 0% at 65; 19% take children; 4% are for women only and 3% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Dexmedetomidine as an add-on Sedative for Endobronchial UltrasoundNov 9, 2026NCT07926542

Studies

Recruiting first, then most recently updated. Showing 50 of 77. Browse all 77 → or search them.